The effect of a soy-yoghurt-honey product on overweight, obesity and related health risk factors. A review

Sadaf koohkan, Aloys Berg

Abstract


The prevalence of overweight and obesity is rising worldwide despite increased spending on weight loss programs. People living with obesity have heard the messages but find it difficult to act upon them (Thomas et al., 2008). In fact, there is an agreement in therapeutic recommendations that people who are overweight and obese need to be counselled and given perspective and practical strategies for lifestyle changes (Saris, 2001)

The soy-yoghurt-honey formula (SYHF) which is described in this review with special focus to its effectiveness on weight control and metabolic regulation was established more than thirty years ago as a health product in Bienenbüttel, Germany.
Meanwhile this product is approved as a food supplement (50 g portion solved in 200ml water) as well as a suitable meal replacement product (1g per kg normal body weight referred to Broca Index) which can support the prevention and therapy of overweight and obesity in adults. Furthermore, this formula is an important part of “The Almased Concept against Overweight and Obesity and Related Health Risk (ACOORH)” and the basis of a recently started multicenter randomized clinical trial to confirm the effects of Almased® on body composition and comorbidities in non-diabetic, viscerally fat-distributed overweight or obese patients with at least one additional comorbidity of the metabolic syndrome and with a special focus on the pre-diabetic state (Berg et al., 2015; Berg et al., 2016).


Keywords


Soy, Yoghurt, Honey, Meal replacement, Weight management , Metabolic syndrome, Diabetes Type2, Muscle mass preservation, Quality of life

Full Text:

 Subscribers Only

References


- Al-Waili N, Salom K, Al-Ghamdi A, Ansari MJ, Al-Waili A, Al-Waili T. Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia. J Med Food. 2013; 16: 1063-78.

- Anderson JW, Hoie LH. Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr. 2005; 24:210-6.

- Astrup A, Grunwald GK, Melanson EL, Saris WHM, Hill JO. The role of low-fat diets in body weight control: a meta-analysis of ad libitum intervention studies. Int J Obes Relat Metab Disord, 2000;24:1545–52

- Astrup A, Rössner S. Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev. 2000; 1:17-9.

- Astrup Arne (2005). The satiating power of protein: A key to obesity prevention? Am J Clin Nutr, 2005; 82(1): 1-2

- Belitz, H.-D., Grosch W. Lehrbuch der Lebensmittelchemie. 7. Auflage, Springer Verlag, Berlin Heidelberg NewYork, 2013

- Berg A, Frey I, Deibert P, Landmann U, König D, Schmidt-Trucksäss A, Rücker G, Kreiter A, Berg A, Dickhuth HH. Gewichtsreduktion ist machbar. Halbjahresergebnisse einer klinisch kontrollierten, randomisierten Interventionsstudie mit übergewichtigen Erwachsenen. Ernährungs-Umschau, 2003; 50: 386-393

- Berg A, Frey I, Landmann U, Deibert P, König D, Berg A, Dickhuth HH. Gewichtsreduktion durch Lebensstilintervention: Einjahresergebnisse einer klinisch kontrollierten, randomisierten Studie mit übergewichtigen Erwachsenen. Ernährungs-Umschau, 2005; 52:310-314

- Berg A, Landmann U. Klinische Erfahrungen zum Einsatz eines kalorienreduzierten Mahlzeitenersatzes. AdipositasSpektrum. 2007; 6:20- 24

- Berg A, Berg A jr, Frey Ingrid, König Daniel, Predel HG. Exercise based lifestyle intervention in obese adults – Results of the intervention study M.O.B.I.L.I.S. Dtsch Arztebl 2008a; 105: 197-203.

- Berg A, König D, Deibert P, Landmann U, Frey I, Kloock B, Gollhofer A. Favorable metabolic properties of a soy-honey-yoghurt product for meal replacement in overweight subjects with atherogenic risk. Atherosclerosis 2008b;9:253

- Berg A. Aktuelle Ergebnisse zur Wirkung und Wirkweise von Almased® als Mahlzeitenersatz. 2012, 13. Jahrestagung der Österreichisches Adipositasgesellschaft, Leibnitz Schloss Seggau, Austria.

- Berg A. Einfluss von Almased auf Körperkomposition und Stoffwechsel: Details zu Methoden und Ergebnissen einer randomisierten, kontrollierten Interventionsstudie mit übergewichtigen Erwachsenen, 2013a. 14. Jahrestagung der Österreichisches Adipositasgesellschaft, Leibnitz Schloss Seggau, Austria.

- Berg A, Schaffner D, Stensitzky A, Deibert P, König D. A soy-yoghurt-honey product improves body weight as well as metabolic milieu even after 6 weeks of intervention. J Diabetes. 2013b; 5(s1):77.

- Berg A, Koohkan S, Kempf K, Martin St, McCarthy D, Toplak H. The ALMASED Concept against Overweight and Obesity and Related Health Risk (ACOORH) has started. Diabetes Technology & Therapeutics. 2015, 17(S1): A-140-141.

- Berg A, Koohkan S, Banzer W, Braumann KM, Führer D, Halle M, Martin St, Predel G, Toplak H. The ALMASED Concept against Overweight and Obesity and Related Health Risk (ACOORH) – first results of an interims analysis. Diabetes Technology & Therapeutics. 2016, 18(S1): A-131-132.

- Berg A jr, Koohkan S, Deibert P, Schaffner D, König D, Bisse E, Berg A. Effects of isoflavon-rich soy-based supplement on cognitive function in postmenopausal women. 22nd Nordic Congress of Gerontology, Gothenburg, 2014

- Bogdanov S., Jurendic T, Sieber R, Gallmann P. Honey for Nutrition and Health: a Review. American Journal of the College of Nutrition. 2008; 27: 677-689

- Brown WJ, Dobson AJ, Mishra G: What is a healthy weight for middle aged women?. Int J Obes Relat Metab Disord. 1998, 22: 520-527.

- Brown WJ, Mishra G, Kenardy J, Dobson A: Relationships between body mass index and well-being in young Australian women. Int J Obes Relat Metab Disord. 2000, 24: 1360-1368.

- Cassidy A. Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr Opin Lipidol. 1999; 10: 47–52

- Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond). 2008; 32:619-28.

- Crane E. “The archaeology of beekeeping.” London: Gerald Duckworth & Co.,1983.

- Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293:43-53.

- Deibert P, König D, Schmidt-Trucksäss A, Zaenker KS, Frey I, Landmann U, Berg A (2004). Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord 2004; 28:1349-1352

- Deibert, P., König, D., Vitolins, M. Z., Landmann, U., Frey, I., Zahradnik, H. P., & Berg, A. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre-versus postmenopausal women. Nutrition journal. 2007; 6(1): 31

- Deibert P, König D, Kloock B, Groenefeld M, Berg A. Glycaemic and insulinaemic properties of some German honey varieties. Eur J Clin Nutr. 2010; 64:762-4.

- Deibert P, Solleder F, König D, Vitolins MZ, Dickhuth HH, Gollhofer A, Berg A. Soy protein based supplementation supports metabolic effects of resistance training in previously untrained middle aged males. Aging Male. 2011a; 14:273-9.

- Deibert P, Lutz L, Konig D, Zitta S, Meinitzer A, Vitolins MZ, Becker G, Berg A. Acute effect of a soy protein-rich meal-replacement application on renal parameters in patients with the metabolic syndrome. Asia Pac J Clin Nutr. 2011b; 20: 527-34.

- Drøyvold WB, Nilsen TI, Krüger O, Holmen TL, Krokstad S, Midthjell K, Holmen J. Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway. Int J Obes (Lond). 2006; 30: 935-9.

- Doll HA, Petersen SE, Stewart-Brown SL: Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. 2000, 8: 160-170.

- Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB: Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003, 27: 260-268.

- Erejuwa OO, Sulaiman SA, Wahab MS. Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules. 2011; 17: 248-66.

- Erejuwa OO, Sulaiman SA, Wahab MS. Honey - A novel antidiabetic agent. Int J Biol Sci. 2012a; 8:913-34.

- Erejuwa OO, Sulaiman SA, Ab Wahab MS. Honey: a novel antioxidant. Molecules. 2012b; 17: 4400-23.

- Ernst ND, Cleeman JI. National cholesterol education program keeps a priority on lifestyle modification to decrease cardiovascular disease risk. Curr Opin Lipidol. 2002; 13:69-73

- Farr SA, Yamada KA, Butterfield DA, Abdul HM, Xu L, Miller NE, Banks WA, Morley JE: Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology. 2008, 149: 2628-2636.

- Fine JT, Colditz GA, Coakley EH, Moseley G, Manson JE, Willett WC, Kawachi I: A prospective study of weight change and health-related quality of life in women. JAMA. 1999, 282: 2136-2142.

- Fontaine KR, Bartlett SJ, Barofsky I: Health-related quality of life among obese persons seeking and not currently seeking treatment. Int J Eat Disord. 2000, 27: 101-105

- Jeong SK, Nam HS, Son MH, Son EJ, Cho KH: Interactive effect of obesity indexes on cognition. Dement Geriatr Cogn Disord. 2005, 19: 91-96.

- Jones R. Honey and healing through the ages. In Munn P, Jones R (ed): “Honey and healing.” Cardiff: International Bee Research Association IBRA, 2001: 1-4

- Kempf K, Schloot N, Gärtner B, Keil R, Schadewaldt P, Martin S. Proteinreiche Ersatzkost reduziert signifikant und langfristig den täglichen Insulinbedarf, den HbA1c und das Gewicht bei Patienten mit Typ 2 Diabetes mellitus, die mehr als >100 IE Insulin pro Tag benötigen. Diabetologie und Stoffwechsel 2012; 7:130

- Khaodhiar L, McCowen KC, Blackburn GL: Obesity and its comorbid conditions. Clin Cornerstone 1999, 2:17-31

- König D, Deibert P, Frey I, Landmann U, Berg A. Effect of meal replacement on metabolic risk factors in overweight and obese subjects. Ann.Nutr.Metab 2008; 52:74-8.

- König D, Muser K, Berg A, Deibert P. Fuel selection and appetite-regulating hormones after intake of a soy protein-based meal replacement. Nutrition. 2012; 28:35-9.

- König, D., Kookhan, S., Schaffner, D., Deibert, P., & Berg, A. A meal-replacement regimen improves blood glucose levels in prediabetic healthy subjects with impaired fasting glucose. Nutrition, 2014; 30:1306–1309

- König D, Zdzieblik D, Deibert P, Berg A, Gollhofer A, Büchert M. Internal Fat and Cardiometabolic Risk Factors Following a Meal-Replacement Regimen vs. Comprehensive Lifestyle Changes in Obese Subjects. Nutrients. 2015; 7:9825-33.

- Kritz-Silverstein, D, Von Mühlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: the Soy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause, 10:196-202.

- Koohkan S., Schaffner D., Milliron B. J., Frey I., König D., Deibert P., Berg A. The impact of a weight reduction program with and without meal-replacement on health related quality of life in middle-aged obese females. BMC women's health, 2014; 14(1):45

- Koohkan S, Baer M, Vitolins MZ, König D, Bisse E, Berg A. Influence of soy protein intake on blood isoflavone levels, thyroid and sex hormone concentrations in women, Poster presented at the American Women Healthcare & Fitness Summit, 20.-22.07.2015, San Francisco, USA

- Koohkan S, Golesorkhi M, Vitolins MZ, H McCarthy DH, Deibert P, König D, Berg A. The influence of a meal replacement formula on leptin regulation in obese adults. J Hum Nutr Food Sci 2016 (in press)

- Larson-Meyer DE, Willis KS, Willis LM, Austin KJ, Hart AM, Breton AB, Alexander BM. Effect of honey versus sucrose on appetite, appetite-regulating hormones, and postmeal thermogenesis.J Am Coll Nutr. 2010; 29: 482-93.

- Lagerstrøm, D, Berg A, Haas U, Hamm M, Göhner W, Fuchs R, Predel HG, Berg A. Das M.O.B.I.L.I.S. Schulungsprogramm. Bewegungstherapie und Lebensstilintervention bei Adipositas und Diabetes. Diabetes aktuell, 2013; 11:5-11

- Lee YB, Lee HJ, Sohn HS. Soy isoflavones and cognitive function, J Nutr Biochem. 2005; 16(11):641-9.

- Lule VK, Garg S, Pophaly SD, Hitesh, Tomar SK. Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide. J Food Sci. 2015; 80:R485-94.

- Marchesini G, Bellini M, Natale S, Belsito C, Isacco S, Nuccitelli C, Pasqui F, Baraldi L, Forlani G, Melchionda N: Psychiatric distress and health-related quality of life in obesity. Diabetes Nutr Metab. 2003, 16: 145-154

LePen C, Levy E, Loos F, Banzet M, Basdevant A: Specific scale compared with generic scale: a double measurement of the quality of life in a French community sample of obese subjects. J Epidemiol Commun Health. 1998, 52: 445-450. 10.1136/jech.52.7.445

- Martínez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG, Louk JA, Rose DJ, Kyureghian G, Peterson DA, Haub MD, Walter J. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013; 7:269-80.

- McCrory MA, Gomez TD, Bernauer EM, Mole PA: Evaluation of a new air displacement plethysmograph for measuring human body composition. Med. Sci. Sports Exerc. 1995; 27:1686-1691.

- Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999; 70:439–49

- Nemoseck TM, Carmody EG, Furchner-Evanson A, Gleason M, Li A, Potter H, Rezende LM, Lane KJ, Kern M. Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res. 2011; 31: 55-60.

- North American Menopause Society. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause. 2011l; 18:732-53.

- Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007; 369:71-7.

- Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000; 133:92-103.

- Rolls BJ, Hetherington M, Burley VJ. The specificity of satiety: the influence of foods of different macronutrient content on the development of satiety. Physiol Behav, 1988; 43:145–53

- Saris WH. Very-low calorie diets and sustained weight loss. Obes Res. 2001, 9:295-301

- Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999; 129:758S-767S.

- Singh BP, Vij S, Hati S. Functional significance of bioactive peptides derived from soybean. Peptides. 2014; 54: 171–179

- Sullivan M, Karlsson J, Sjöström L, Taft C: Why quality of life measures should be used in the treatment of patients with obesity. International Textbook of Obesity. Edited by: Björntorp P. 2001, New York: John Wiley & Sons, 485-510.

- Summerbell CD, Watts C, Higgins JP, Garrow JS (1998). Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients. BMJ 1998; 317: 1487–1489

- Thomas S.L, Hyde J, Karunaratne A, Herbert D, Komesaroff PA. Being ‘fat’ in today’s world: a qualitative study of the lived experiences of people with obesity in Australia. Health Expectations, 2008; 11:321–330.

- Udenigwe CC, Aluko RE. Food Protein‐Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits. Journal of food science. 2012; 77: 11-24

- Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci. 2007; 4:72-82.

- Wadden TA, Phelan S. Assessment of quality of life in obese individuals. Obes Res. 2002, 10 (Suppl 1): 50S-57S.

- Wagner JD, Zhang L, Shadoan MK, Kavanagh K, Chen H, Tresnasari K, Kaplan JR, Adams MR. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism. 2008; 57(7 Suppl 1):S24-31.

- Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000; 21:697-738.

- Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Beneficial modulation of the gut microbiota. FEBS Lett. 2014; 588:4120-30.

-Wasielewski H, Alcock J, Aktipis A. Resource conflict and cooperation between human host and gut microbiota: implications for nutrition and health. Ann NY Acad Sci. 2016; 1372: 20-8.

- Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wahala K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998; 128:1710–5

- Wechsler JG, Wenzel H, Swobodnik W, Ditschuneit H: Modified fasting in the therapy of obesity. A comparison of total fasting and low-calorie diets of various protein contents. Fortschr Med 1984, 102:666-668.

- Weigle DS, Breen PA., Matthys CC, Callahan HS, Meeuws KE, Burden VR, Purnell JQ. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr, 2005; 82:41-48.

- Wirth A, Wabitsch M, Hauner H. The prevention and treatment of obesity. Dtsch Arztebl Int 2014; 111:705-13.

- Zaloga GP, Siddiqui RA. Biologically active dietary peptides. Mini Rev Med Chem. 2004; 4:815-21.




DOI: http://dx.doi.org/10.18103/imr.v2i7.149

Refbacks

  • There are currently no refbacks.
Copyright 2016. All rights reserved.